IP Library Granted Patent US 10,208,300
Granted Patent B2
US 10,208,300 · App. 15/226,593 · Granted Feb 19, 2019

Extracellular hyaluronidase from

Inventors: Luciano Messina (Abano Terme, IT); Susanna Vaccaro (Abano Terme Pd, IT); Salvatore Caruso (Abano Terme Pd, IT); Giovanni Gennari (Abano Terme, IT)
Assignee: FIDIA FARMACEUTICI S.P.A.
C12N9/2474A61K38/47A61K39/35A61K45/06C07K14/315C07K14/43595C12N9/2408C12Y302/01035A61K38/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,208,300
App. No.
15/226,593
Granted
Feb 19, 2019
Kind
B2
Abstract

A process for preparing Streptomyces koganeiensis ATCC 31394 hyaluronidase by obtaining hyaluronidase having molecular weight of 21.6 kDalton, which has hyaluronidase activity and stability markedly higher than those of the hyaluronidase obtained from such microorganism to date.

Claims (12)

1. A process for preparing hyaluronidase from Streptomyces koganeiensis ATCC 31394 comprising:

a) fermenting Streptomyces koganeiensis ATCC 31394 and obtaining a supernatant;

b) submitting the supernatant obtained from the fermentation of Streptomyces koganeiensis ATCC 31394 to weak cation-exchange chromatography and isolating a protein fraction with hyaluronidase activity;

c) submitting the protein fraction with hyaluronidase activity from step b) to diafiltration and strong anion-exchange chromatography and isolating a protein fraction with hyaluronidase activity;

d) submitting the protein fraction with hyaluronidase activity from step c) to strong cation-exchange chromatography and isolating a protein fraction with hyaluronidase activity;

e) submitting the protein fraction with hyaluronidase activity from step d) to strong anion-exchange chromatography and isolating a protein fraction with hyaluronidase activity, thereby obtaining hyaluronidase consisting of:

a) an N-terminal amino acid sequence set forth in SEQ ID NO: 1,

b) a molecular weight of 21.6 kDa,

c) an isoelectric point (pI) ranging from 4.4 to 4.8,

d) a relative enzymatic activity equal to or higher than 40,000 I.U./mg, measured against hyaluronidase BRP from bovine testis EDQM, FIP, Hyaluronidase, H1115000 and

e) a HPLC purity degree higher than 98%, wherein

said hyaluronidase is stable in aqueous solution and not sensitive to the action of proteolytic enzymes.

Priority Claims (1)
IT MI2009A0831 · May 14, 2009 · national
Continuity (2)
Division 13318476
Related Publication 20170101634A1 · Apr 13, 2017